Increased ALT, myalgia, myositis, dehydration, hypercalcaemia, thrombocytopenia, rhabdomyolysis, neuromypathy, toxic encephalopathy, maculopapular rash, pruritic rash (3.0%, respectively). This evidence concerns the gene GPT and Myalgia.